Hamlet BioPharma is a pharmaceutical company. Most research and development is carried out in the field of protein-lipid complexes, which are used in the treatment of various forms of cancer. The company has developed a tumoricidal protein-lipid complex that mainly is used in the treatment of breast cancer, bladder cancer, as well as in cases of cancer that are hard to treat. The company is based in Lund.

Quotes for Hamlet BioPharma AB

Right Now

+/-
0.05
%
4,17%
Latest
1.25
High
1.325
Low
1.205
Volume
173 933
Turnover (SEK)
218 636
Market Value (MSEK)
157,5
Time (Latest trade)

Board

CEO

  • Martin Erixon (tf)

Chairperson of the Board

  • Catharina Svanborg

Board

  • Bill Hansson
  • Carl-Johan Wachtmeister
  • Helena Lomberg
  • Magnus Nylen
  • Ulla Trädgårdh

Videos

Largest Owners

Name Capital % Votes % Date
Catharina Svanborg 48,35 82,73 2023-09-27
Avanza Pension 4,51 1,23 2023-09-27
Nordnet Pensionsförsäkring 4,31 1,12 2023-09-27
Rolf Karlsson 2,36 0,61 2023-09-27
Hans Nygren 1,64 0,42 2023-09-27
Försäkringsaktiebolaget Skandia 0,68 0,18 2023-09-27
Olle Jönsson 0,63 0,16 2023-09-27
Fredrik Herslow 0,54 0,14 2023-09-27
Jan Zetterberg 0,44 0,11 2023-09-27
Gramsh Gashi 0,41 0,11 2023-09-27
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2023-12-14 Extra bolagsstämma 2024

  • 2024-02-22 Delårsrapport 2024-Q2

  • 2024-05-25 Delårsrapport 2024-Q3

  • 2024-08-28 Bokslutskommuniké 2024

  • 2024-11-21 Årsstämma 2024

  • 2024-11-21 Delårsrapport 2025-Q1